Abstract
Myocardial injury during percutaneous coronary intervention (PCI) occurs in 10%–40% of cases. Several studies have shown that adenosine and nicorandil have myocardial protective effects against angioplasty-related myocardial injury. We conducted a prospective, randomized, open-label study to investigate the effect on myocardial protection of intracoronary adenosine and nicorandil combination therapy.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call